Inside the aging brain, a molecular contest between two opposing chemical forces determines whether proteins remain functional or collapse into the harmful clumps associated with neurodegeneration. Researchers from an international team have mapped this tug-of-war — oxidation accumulating with age on one side, hydrogen sulfide-driven persulfidation holding the line on the other — and found that when the balance tips, the consequences resemble the very diseases humanity most fears in its later years. The discovery, published in Nature Structural & Molecular Biology, carries a rare note of hope:
Aging Oxidation Drives Brain Proteins Into Harmful Clumps, Study Finds
Compounds that boost hydrogen sulfide can reverse protein aggregation
Mark
So the core finding is that two chemical processes are fighting each other as we age—one breaking proteins down, one protecting them?
Mimi
Exactly. Oxidation accumulates and pushes proteins toward clumping. Persulfidation, driven by hydrogen sulfide, keeps them fluid and working. When you're young, that balance holds. When you're old, oxidation wins.
Luke
How do we know the balance actually matters in human brains? The study is in mice.
Mimi
Fair point. The mice with failed hydrogen sulfide production showed shorter lifespans and neurodegeneration-like traits. That's a strong signal, but you're right—it's not human data yet.
Mark
And the ergothioneine compound—they showed it can reverse the damage?
Mimi
In cells, yes. They demonstrated that boosting hydrogen sulfide levels can reverse protein aggregation that had already begun. That's the promising part.
Luke
In cells, though. Not in living animals, not in humans. That's a meaningful gap between "this works in a dish" and "this could be a drug."
Mimi
Absolutely. But it's the first evidence that the process is reversible at all. Before this, you might have assumed aggregated proteins were permanent damage.
Mark
Why does hydrogen sulfide specifically have this protective effect?
Mimi
It enables persulfidation—a chemical modification that keeps proteins in a flexible state. Without it, proteins lock into solid forms.
Luke
And we know hydrogen sulfide production declines with age?
Mimi
The study shows that when it fails, bad things happen. Whether it naturally declines is a separate question the paper doesn't directly address.
Mark
So the next step would be testing these hydrogen sulfide-boosting compounds in animals, then humans?
Mimi
That's the logical path. If it works in mice the way it works in cells, you'd have a real therapeutic target.
Il Polso
- As brains age, oxidation steadily pushes key proteins like synapsin 1 and G3BP2 toward harmful solid aggregates, disrupting the cellular communication and stress responses neurons depend on.
- When hydrogen sulfide production fails entirely, the protective process of persulfidation disappears, and mice in the study developed shortened lifespans alongside neurodegeneration-like traits — a stark signal of how critical this balance is.
- The seesaw metaphor is precise: oxidation and persulfidation are not background noise but the central mechanism governing whether brain proteins stay fluid and functional or lock into dysfunction.
- Crucially, the damage is not irreversible — ergothioneine and similar compounds that boost hydrogen sulfide levels were shown to restore aggregated proteins to a healthy state in cellular experiments.
- The field now has a specific, targetable molecular process to pursue, moving the science of brain aging from description toward the possibility of intervention.
Inside the aging brain, a molecular contest between two opposing chemical forces determines whether proteins remain functional or collapse into the harmful clumps associated with neurodegeneration. Researchers from an international team have mapped this tug-of-war — oxidation accumulating with age on one side, hydrogen sulfide-driven persulfidation holding the line on the other — and found that when the balance tips, the consequences resemble the very diseases humanity most fears in its later years. The discovery, published in Nature Structural & Molecular Biology, carries a rare note of hope: compounds that restore hydrogen sulfide levels can reverse protein aggregation in cells, suggesting that the brain's decline may be not only explainable but, in time, addressable.
An international research team, including Martín Hugo from the Autonomous University of Barcelona, has identified a molecular tug-of-war inside aging brains that may explain how proteins go wrong as we grow older. Published in Nature Structural & Molecular Biology, the work describes two opposing chemical processes that determine whether key brain proteins remain functional or clump into the harmful aggregates associated with neurodegeneration.
The mechanism centers on oxidation — the same process that rusts metal and browns fruit. As we age, oxidation accumulates in brain proteins, pushing them toward excessive condensation and eventually solid aggregates that can no longer function. The body's counterforce is persulfidation, regulated by hydrogen sulfide production, which keeps proteins in a fluid, working state. This balance governs what scientists call liquid-liquid phase separation in proteins like synapsin 1 and G3BP2, both critical to how neurons communicate and how cells handle stress.
In a healthy, younger brain, the seesaw holds. But as oxidation accumulates, it tips. When hydrogen sulfide production fails entirely, proteins become trapped in dysfunctional states — and in the mice studied, this failure produced shortened lifespans and traits that closely resemble human neurodegeneration, suggesting this balance is not merely one factor among many but something more fundamental.
What makes the research potentially transformative is the discovery of reversal. Compounds that raise hydrogen sulfide levels — ergothioneine among them — were shown to restore aggregated proteins to their fluid, functional state in cellular experiments. This opens a direct path toward therapeutic intervention: if the mechanism holds in human brains as it does in mice, drugs targeting hydrogen sulfide production could one day slow or reverse the protein damage driving age-related brain disease. The work does not yet constitute a treatment, but it names a specific, targetable process — and that is where cures tend to begin.
A team of international researchers, including Martín Hugo from the Department of Biochemistry and Molecular Biology at the Autonomous University of Barcelona, has identified a molecular tug-of-war happening inside aging brains—one that may explain how proteins go wrong as we grow older. The work, published in Nature Structural & Molecular Biology, describes two opposing chemical processes that determine whether key brain proteins remain functional or clump into the harmful aggregates associated with neurodegeneration.
The mechanism centers on oxidation, the same process that rusts metal and browns fruit. As we age, oxidation accumulates in brain proteins, pushing them toward a state called excessive condensation. This is where proteins begin to clump together, forming solid aggregates that can no longer do their jobs. But the body has a counterforce: a process called persulfidation, which is regulated by hydrogen sulfide production. When persulfidation works properly, it keeps proteins in a fluid, functional state—preventing them from locking into those damaging clumps.
The balance between these two processes controls what scientists call liquid-liquid phase separation in specific proteins, including synapsin 1 and G3BP2. Both of these proteins are critical to how neurons communicate and how cells respond to stress. Think of it as a seesaw: oxidation pushes proteins toward solid aggregation on one side, while hydrogen sulfide-driven persulfidation keeps them flexible and working on the other. In a healthy, younger brain, this balance holds. But as oxidation accumulates with age, the seesaw tips.
The consequences of losing this balance are severe. When hydrogen sulfide production fails—when the counterweight disappears—proteins become trapped in an abnormal, dysfunctional state. In the mice studied, this failure led to shorter lifespans and the emergence of traits that resemble neurodegeneration. The animals showed the kinds of protein dysfunction and cellular stress that characterize age-related brain diseases in humans. This finding suggests that the oxidation-persulfidation balance is not merely one factor among many in aging; it appears to be fundamental to whether the brain stays healthy or begins to fail.
What makes this research potentially transformative is a discovery about reversal. The team found that compounds capable of increasing hydrogen sulfide levels—ergothioneine is one example—can reverse the protein aggregation process in cells. This is not a theoretical possibility; it happened in their experiments. A molecule that boosts the body's own hydrogen sulfide production can push the seesaw back toward balance, restoring proteins to their fluid, functional state even after they have begun to aggregate. This opens a direct path toward therapeutic intervention. If the mechanism holds in human brains as it does in mice, drugs designed to raise hydrogen sulfide levels could potentially slow or even reverse the protein damage that drives age-related neurodegeneration. The work does not yet constitute a treatment, but it identifies a specific, targetable process that appears to control whether brain proteins age gracefully or deteriorate.
Citazioni salienti
When intracellular hydrogen sulfide production fails, proteins become trapped in an abnormal state, and the mice studied exhibit shorter lifespans and traits resembling neurodegeneration.— Research findings
Compounds that increase hydrogen sulfide levels can reverse protein aggregation effects in cells, opening a promising avenue for addressing age-related brain diseases.— Research team
Vuoi la storia completa?
Leggi l'originale su Medical Xpress ↗
Science & Space